ArticleAmerican journal of cancer research2015

Semenogelin I promotes prostate cancer cell growth via functioning as an androgen receptor coactivator and protecting against zinc cytotoxicity.

Hitoshi Ishiguro et al.PubMed ↗Full text ↗

No numbers read from the abstract.